ADDvise order intake increased by 33% in Q1 2019 - Regulatory information

08-04-2019   Regulatory press release

ADDvise Group had a strong order intake during the first quarter of the year. Order intake increased by 33 percent compared with the previous year. The total order intake amounted to SEK 84.4 million.

ADDvise Group's total order intake during the first quarter of 2019 amounted to SEK 84.4 million, compared with SEK 63.5 million in the first quarter of 2018. The total increase was 33 percent and organic growth was 20 percent compared to Q1 2018.

-      The first quarter's order intake has started strongly. The trend has continued into the beginning of the second quarter. Our US operations have been the driver of the increase, says Rikard Akhtarzand in a comment on the order intake. 

For further information, please contact:

Rikard Akhtarzand, CEO
+46 765-25 90 71 

Important information:

This information is by ADDvise Group AB required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on April 8, 2019 at 10:45 CET.

About ADDvise Group

ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. ADDvise Group’s shares are listed on Nasdaq First North and Mangold Fondkommission AB, +46 8 503 015 50,, is the Company's Certified Adviser. Additional information is available at 

Latest press releases

ADDvise announces preliminary result for 2022 which is stronger than expected


The preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…

ADDvise receives order worth USD 3.5 million


ADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…

ADDvise receives order worth USD 1.8 million


ADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…